Literature DB >> 7661115

Intestinal nutrient transport in genetically obese mice.

R P Ferraris1, R R Vinnakota.   

Abstract

The small intestine of obese animals supplies nutrients to a metabolic live mass (body weight 0.75) that is much higher than that of age- and sex-matched lean animals. To determine the mechanisms of adaptation of the small intestine to obesity, we determined the rate of uptake of D-glucose and five amino acids, the site density of intestinal D-glucose transporters, and the permeability of the absorptive mucosa in isolated everted intestinal sleeves of genetically obese male mice (C57BL/6J ob/ob) and their lean male littermates. Intestinal D-glucose, proline, alanine, aspartate, leucine, and lysine uptakes per milligram were each similar in the small intestine of obese and control mice. Mucosal permeability, site density of intestinal D-glucose transporters, and their affinity for phlorizin were also each similar between obese mice and their lean controls. In contrast, intestinal D-glucose, proline, alanine, aspartate, leucine, and lysine uptakes per centimeter of small intestine were each approximately 40% greater in obese mice compared with lean controls (P < 0.001 to P < 0.08, depending on the nutrient and intestinal region). Differences in total absorptive capacity for any nutrient between the small intestine of obese and lean mice reflect mainly differences in intestinal weights. Thus, genetic obesity is associated with increased intestinal growth, which augments absorption of all types of nutrients. The ratio of intestinal absorptive capacity to metabolic mass, and of intestinal mass to metabolic mass, does not change with obesity, indicating that in mice, changes in intestinal mass and in absorptive capacity are directly proportional to changes in metabolic mass.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7661115     DOI: 10.1093/ajcn/62.3.540

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  23 in total

Review 1.  Gut microbiome, obesity, and metabolic dysfunction.

Authors:  Herbert Tilg; Arthur Kaser
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

2.  Leptin effect on intestinal galactose absorption in ob/ob and db/db mice.

Authors:  C Iñigo; A Barber; M P Lostao
Journal:  J Physiol Biochem       Date:  2004-06       Impact factor: 4.158

3.  Impact of Roux-en-Y gastric bypass surgery on rat intestinal glucose transport.

Authors:  Adam T Stearns; Anita Balakrishnan; Ali Tavakkolizadeh
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-11       Impact factor: 4.052

4.  Insulin/IGF-1 enhances intestinal epithelial crypt proliferation through PI3K/Akt, and not ERK signaling in obese humans.

Authors:  Weinan Zhou; Blair M Rowitz; Megan J Dailey
Journal:  Exp Biol Med (Maywood)       Date:  2018-06-27

5.  Long-term effect of parasympathetic or sympathetic denervation on intestinal epithelial cell proliferation and apoptosis.

Authors:  Elizabeth A Davis; Martha C Washington; Emily R Yaniz; Heidi Phillips; Ayman I Sayegh; Megan J Dailey
Journal:  Exp Biol Med (Maywood)       Date:  2017-08-02

6.  Rapid upregulation of sodium-glucose transporter SGLT1 in response to intestinal sweet taste stimulation.

Authors:  Adam T Stearns; Anita Balakrishnan; David B Rhoads; Ali Tavakkolizadeh
Journal:  Ann Surg       Date:  2010-05       Impact factor: 12.969

Review 7.  Sodium-glucose cotransport.

Authors:  Søren Brandt Poulsen; Robert A Fenton; Timo Rieg
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-09       Impact factor: 2.894

Review 8.  Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases.

Authors:  Craig Sturgeon; Alessio Fasano
Journal:  Tissue Barriers       Date:  2016-10-21

Review 9.  Obesity and cancer pathogenesis.

Authors:  Nathan A Berger
Journal:  Ann N Y Acad Sci       Date:  2014-04       Impact factor: 5.691

10.  Disrupted circadian rhythmicity of the intestinal glucose transporter SGLT1 in Zucker diabetic fatty rats.

Authors:  Hina Y Bhutta; Tara E Deelman; Stanley W Ashley; David B Rhoads; Ali Tavakkoli
Journal:  Dig Dis Sci       Date:  2013-04-30       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.